From Name:
From Email:
To Name:
To Email:

Optional Message:


 Sirolimus lowers NMSC risk in transplant recipients

from Renal & Urology News

Switching from a calcineurin inhibitor (CNI) to sirolimus for immunosuppression may decrease the risk of nonmelanoma skin cancer (NMSC) in kidney transplant recipients with a history of NMSC, according to researchers. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063